
Overview
Katherine Ikard Stewart, M.D., M.B.A., is an assistant professor at the Johns Hopkins University School of Medicine. Her clinical expertise includes gynecologic cancers, fertility sparing surgery and minimally invasive surgery. Dr. Stewart received her undergraduate degree from the University of San Diego. She earned her medical degree and her M.B.A. in health organization management from Texas Tech University, and she completed residency training in gynecology and obstetrics at The Johns Hopkins Hospital. Dr. Stewart spent two years as a reproductive endocrinology and infertility fellow at Johns Hopkins, then completed a four-year gynecologic oncology fellowship at the University of Texas MD Anderson Cancer Center. She is particularly interested in the effect of cancer on reproductive health and pushing the envelope in the use of fertility sparing treatment strategies. Her current research investigates the impact of fertility sparing surgery techniques on oncologic and reproductive outcomes. Dr. Stewart believes in the importance of shared decision making and individualized treatment plans for all patients to meet their specific goals and optimize their quality of life. She seeks to provide multidisciplinary care to patients with gynecologic cancer.
Her clinical expertise encompasses Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Endometrial Cancer, and Virilizing Ovarian Tumor.
Dr. Stewart is board certified in American Board Of Obstetrics And Gynecology. Dr. Stewart is currently accepting new patients.
Specialties
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
600 N Wolf St, Baltimore, MD 21287
10710 Charter Dr, Suite 420, Columbia, MD 21044
10755 Falls Rd, Lutherville, MD 21093
5759 Cedar Ln, Columbia, MD 21044
5755 Cedar Ln, Columbia, MD 21044
601 N Caroline St, Baltimore, MD 21287
Sidney Kimmel Comprehensive Cancer Center
Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine. Dr. Brodsky is currently accepting new patients.
Stoler Outpatient Cancer Clinic
Taofeek Owonikoko is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Owonikoko is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Owonikoko is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Dr. Matthias Holdhoff is a medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a professor of oncology, neurology and neurological surgery at Johns Hopkins University School of Medicine. Dr. Holdhoff’s expertise is in primary brain cancers and central nervous system lymphomas. He earned his medical degree from Freie Universität Berlin, received his doctorate degree at Charité University Medicine Berlin. Dr. Holdhoff completed residency training in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in medical oncology at Johns Hopkins Hospital with research training at the Ludwig Center for Cancer Genetics and Therapeutics (Kinzler-Vogelstein lab). As a clinical investigator in neuro-oncology, his research is focused on novel trials and translational biomarker studies in malignant gliomas and primary central nervous system lymphomas. He has led and contributed to numerous clinical trials, publications and presentations. Dr. Holdhoff serves as the director of the solid tumor inpatient service at the Sidney Kimmel Comprehensive Cancer Center. He is passionately involved in mentoring and teaching of fellows, residents and students. He is the director of the UCNS-certified neuro-oncology fellowship program at Johns Hopkins, and he is a teaching attending physician for the Osler internal medicine residency program. Dr. Holdhoff is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, and Brain Tumor. Dr. Holdhoff is board certified in American Board Of Internal Medicine. Dr. Holdhoff is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Stuart Grossman, M.D., is a professor of oncology at the Johns Hopkins Kimmel Cancer Center. He has served as Principal Investigator and Director of the Central Operations office of the National Cancer Institute-funded phase I/II brain tumor consortia (New Approaches to Brain Tumor Therapy CNS Consortium and the Adult Brain Tumor Consortium) for the past 22 years. He has led many phase I, II, and III institutional and cooperative group translational and clinical brain cancer research projects. Dr. Grossman's expertise is in brain cancers, translational and clinical research, and directing large, multicenter, multidisciplinary clinical trial groups and training programs. Dr. Grossman was an intern and resident at Strong Memorial Hospital in Rochester, NY, and a fellow at the Johns Hopkins University School of Medicine. He received his M.D. from the University of Rochester. Dr. Grossman is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Gliomatosis Cerebri, and Nerve Decompression. Dr. Grossman is board certified in American Board Of Internal Medicine. Dr. Grossman is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Julie R. Brahmer, M.D., M.Sc. is the Director of the Thoracic Oncology Program, Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the Marilyn Meyerhoff Professor in Thoracic Oncology. She also directs the Kimmel Cancer Center on the Johns Hopkins Bayview campus and is co-principal investigator on Johns Hopkins' National Clinical Trials Network. Dr. Brahmer received her undergraduate degree in Chemistry and Philosophy in 1989 from the Creighton University in Omaha, Nebraska and went on to receive her medical degree from the University of Nebraska Medical Center College of Medicine in 1993. Completing her internship and residency in Internal Medicine at the University of Utah, Dr. Brahmer later became the Chief Medical Resident until moving to Baltimore to complete her fellowship in Medical Oncology at the Kimmel Cancer Center at Johns Hopkins. Dr. Brahmer is an active clinical leader in the treatment of lung cancer and mesothelioma. She leads the organization of the multidisciplinary thoracic malignancy conference whose members meet weekly to discuss thoracic malignancy cases that need a multidisciplinary review/approach. Dr. Brahmer's research and clinical practice focuses on the development of new therapies for the treatment and prevention of lung cancer and mesothelioma. Dr. Brahmer's research interests include leading early phase immunotherapy trials of anti-PD-1 antibodies, international phase III studies of immunotherapies in lung cancer and investigator-initiated trials evaluating epigenetic therapies in combination with immunotherapies. She is a member of the American Society of Clinical Oncology and the Eastern Cooperative Oncology Group (ECOG) Thoracic Committee and Cancer Prevention Steering Committee. She is one of the founding Board members for the National Lung Cancer Partnership (formerly Women Against Lung Cancer). Within the National Lung Cancer Partnership, she currently serves as a member and the Chairman of the Scientific Executive Committee. She is also on the medical advisory board of the Lung Cancer Research Fund and the Mesothelioma Applied Research Foundation. Dr. Brahmer is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC). Dr. Brahmer is board certified in American Board Of Internal Medicine. Dr. Brahmer is currently accepting new patients.
Johns Hopkins Outpatient Center
Nirmish Singla is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Singla is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Singla is board certified in American Board Of Urology. Dr. Singla is currently accepting new patients.
Frequently Asked Questions about Dr. Katherine I. Stewart
How do I make an appointment with Dr. Katherine I. Stewart?
You can book an appointment with Dr. Katherine I. Stewart by calling their office at 443-546-1500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Katherine I. Stewart a top-rated expert for Malignant Mixed Mullerian Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Katherine I. Stewart is classified as an Experienced expert for Malignant Mixed Mullerian Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Katherine I. Stewart specialize in?
While Dr. Katherine I. Stewart is a Oncology, they have specific expertise in Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, and Endometrial Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Katherine I. Stewart accept my insurance?
Dr. Katherine I. Stewart accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 443-546-1500 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Endometrial CancerDr. Stewart isExperienced. Learn about Endometrial Cancer.
- Endometrial Stromal SarcomaDr. Stewart isExperienced. Learn about Endometrial Stromal Sarcoma.
- Malignant Mixed Mullerian TumorDr. Stewart isExperienced. Learn about Malignant Mixed Mullerian Tumor.
- Ovarian CancerDr. Stewart isExperienced. Learn about Ovarian Cancer.
- Ovarian CarcinosarcomaDr. Stewart isExperienced. Learn about Ovarian Carcinosarcoma.
- Sertoli-Leydig Cell TumorDr. Stewart isExperienced. Learn about Sertoli-Leydig Cell Tumor.
- Testicular Yolk Sac TumorDr. Stewart isExperienced. Learn about Testicular Yolk Sac Tumor.
- Virilizing Ovarian TumorDr. Stewart isExperienced. Learn about Virilizing Ovarian Tumor.



